Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin

2-Hydroxypropyl-beta-cyclodextrin (HPBCD) is utilized in the formulation of pharmaceutical products and recently orphan designation was granted for the treatment of Niemann–Pick disease, type C. The exact mechanism of HPBCD action and side effects are not completely explained. We used fluorescently...

Descripción completa

Detalles Bibliográficos
Autores principales: Váradi, Judit, Hermenean, Anca, Gesztelyi, Rudolf, Jeney, Viktória, Balogh, Enikő, Majoros, László, Malanga, Milo, Fenyvesi, Éva, Szente, Lajos, Bácskay, Ildikó, Vecsernyés, Miklós, Fehér, Pálma, Ujhelyi, Zoltán, Vasvári, Gábor, Árvai, István, Rusznyák, Ágnes, Balta, Cornel, Herman, Hildegard, Fenyvesi, Ferenc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843445/
https://www.ncbi.nlm.nih.gov/pubmed/31546989
http://dx.doi.org/10.3390/biom9100509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843445/
https://www.ncbi.nlm.nih.gov/pubmed/31546989
http://dx.doi.org/10.3390/biom9100509

Ejemplares similares